By David Burda – With a little extra effort, you always can find something revealing in surveys of healthcare executives, even when a multi-billion dollar, vertically integrated incumbent healthcare company sponsors the survey.
Read More
By David Burda – By now, we all know that hospitals’ level of compliance with the new price transparency rule would not be described as robust. It’s whatever the opposite of robust is. Feeble? Pathetic? Weak? There’s been a lot of speculation as to why even at this point, nearly 18 months after the rule went into effect.
By David Burda – By any measure or definition, we’re a long way from full adoption of value-based care reimbursement in the U.S. The questions are why and what can we do about it? All we know as consumers of medical care and journalists who write about these things are what payers and providers tell us about why payments still aren’t based on outcomes.
By David Burda – Years ago, in a publishing galaxy far, far away, the healthcare business publication that I worked for as a reporter required each news story to be read four times. Every story got four “reads,” as we used to say. At each step, the story got worse as the next read compounded errors introduced and questions raised by the previous read.
By David Burda – As Maya Angelou said, “You can’t really know where you are going until you know where you have been.” I don’t think she was talking about primary care in the U.S., but she might as well have been. Looking at two new reports out this week.
By David Burda – It should come as no surprise that two things that I thought went together in healthcare — value-based care and interoperability — don’t really, at least not yet, according to a recently published study in JAMA Health Forum.
By David Burda – I’ve never been much for company-sponsored surveys. They’re all self-serving, and they reach the same inevitable conclusion: our customers need or want what we’re selling, and you should, too.
By David Burda – AHRQ’s snapshot of the U.S. healthcare system taken through the lens of 233 performance measures in three domains and six subareas under the quality-of-care domain. The 2021 report is a picture of the healthcare system as it was in 2019, a year before the COVID-19 pandemic.
